Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.

Authors

Clark D Russell¹, Jonathan E Millar², J Kenneth Baillie³

Affiliations

¹ University of Edinburgh Centre for Inflammation Research, The Queen's Medical Research Institute Edinburgh, Edinburgh, UK.
² Genetics and Genomics, Roslin Institute, University of Edinburgh, Edinburgh EH25 9RG, UK.
³ Genetics and Genomics, Roslin Institute, University of Edinburgh, Edinburgh EH25 9RG, UK. Electronic address: j.k.baillie@ed.ac.uk.

No abstract available

MeSH terms

Betacoronavirus*
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections / drug therapy*
Evidence-Based Medicine / methods
Glucocorticoids / adverse effects
Glucocorticoids / therapeutic use*
Humans
Pneumonia, Viral / drug therapy*
SARS-CoV-2

Substances

Glucocorticoids

Grants and funding

MC_PC_19059/MRC_/Medical Research Council/United Kingdom